Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02284178 · ClinicalTrials.gov registry record · NA
Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE
A NA study of Respiratory Failure, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 513
- Enrollment target
- 1
- Study location
NCT02284178: Completed NA study of Respiratory Failure, sponsored by University of Central Florida.
NCT02284178 is a NA study of Respiratory Failure that has completed, run by University of Central Florida. The registered enrollment target is 513 participants, below the 4,511-participant average among 40 other Respiratory Failure trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02284178, a NA study of Respiratory Failure, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 513 participants
- Enrollment target
- 1
- Study location
Study Summary
Insertion of a breathing tube to enable treatment with mechanical ventilation (respirator) is often associated with complications, such as infection and lung injury. Leakage of secretions around the breathing tube (microaspiration) is a major factor leading to complications. The investigators propose that a standardized, enhanced oral suction protocol will be effective in reducing microaspiration and harms associated with mechanical ventilation. The investigators hypothesize that those randomized to the enhanced oral suction protocol will have less microaspiration and other ventilator-associated conditions than those in the usual care, standard suction group.
Primary Outcome
Specimens will be obtained every 12 hours for up to 14 days or subject no longer meets inclusion (e.g., extubation, tracheostomy, etc.); tracheal amylase measured in U/L.
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Enhanced oropharyngeal suction
Study Locations (1)
Florida
- Orlando Regional Medical Center - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 513 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT02284178 record still lists
NCT02284178 is an interventional study that assigns participants to a tested intervention. The registered 513 participants enrollment target is mid-sized for trials with a published cap, below the 4,511-participant average among 40 other Respiratory Failure trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT02284178 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02284178 about?
NCT02284178 is a clinical study titled "Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE". Insertion of a breathing tube to enable treatment with mechanical ventilation (respirator) is often associated with complications, such as infection and lung injury. Leakage of secretions around the breathing tube (microaspiration) is a major factor leading to complications. The investigators propos...
What is the current status of trial NCT02284178?
This trial is currently completed. It is a NA study. The enrollment target is 513 participants. The study started on 2014-08. Estimated completion is 2017-12.
What conditions does trial NCT02284178 study?
This clinical trial studies the following conditions: Respiratory Failure.
What interventions are being tested in trial NCT02284178?
The interventions under investigation include: Usual Care (OTHER), Enhanced oropharyngeal suction (OTHER).
Who is sponsoring clinical trial NCT02284178?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02284178 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02284178's enrollment target sits among peer trials
513 10th of 40 higher than 31 of 40 other Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- NCT06585488 · 514 participants · Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
- NCT06716606 · 514 participants · Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia